Final 5-year updated results from a phase 3 study (HELIOS) of ibrutinib plus bendamustine and rituximab (BR) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)


Fraser G., Chanan-Khan A., Demirkan F., Silva R. S., Grosicki S., Janssens A., ...Daha Fazla

LEUKEMIA & LYMPHOMA, cilt.61, ss.106-108, 2020 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 61
  • Basım Tarihi: 2020
  • Dergi Adı: LEUKEMIA & LYMPHOMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.106-108
  • Dokuz Eylül Üniversitesi Adresli: Evet